Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > How low will it go?
View:
Post by BottomBroker on Jul 27, 2023 3:59pm

How low will it go?

And when does NASDAQ delisting become a worry?
Comment by Gbathat on Jul 27, 2023 7:20pm
This drop is confusing and getting concerning. I'm adding as I can and hoping I don't regret it.  
Comment by Speyeder999 on Jul 27, 2023 10:37pm
CEO and Chairman have been silent too long. They need to address shareholders pronto regarding the sinking share price. Fundamentals of the company did not change for over 5 years, if anything, they improved....they've been saying their product is superior than their competitors  (the science backs it up)....they have FDA approval to go into clinic and a robust pipeline....yet, the share ...more  
Comment by FarmerBetsy on Jul 28, 2023 9:26am
BottomBroker, the share price will go where the Boston group wants to put it. Remember very few people know about this closely held company. They have had by design no promotion, anlalyst following, social media etc.. I have in the past referred to Friday April 28th when we were on the upswing then obvious share downturn that day caused by? More recently out of the tsx to consolidate reasons ...more  
Comment by G1945V on Jul 28, 2023 9:40am
So Betsy, are you suggesting that the Boston Group took the stock up to approximately $10 and then turned around and brought it down to where we are now? What's the point of that? If one does not sell their shares and stick it out, one will gain the same way if the Boston Group gains.  G1945V
Comment by FarmerBetsy on Jul 28, 2023 11:29am
Absolutely, the day Acumen July 17th announces positive news the Promis stock on the Nasdaq opens at $3.26 a high of 8.95 and closes at 6.19. Nearly 14 million shares that day which i don't know how many total years of share trading you would have to add up to get this amount of volume.  The stock was shorted on July 14th the highest since January of this year. Some folks new the stock ...more  
Comment by M101 on Jul 28, 2023 1:15pm
PMN has always been shorted on spikes, and the big spike associated (dubiously) with Ray Blanco had nothing to do with FSG et al.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities